It looks like this study which has made the news:
http://m.pnas.org/content/early/2016/05/25/1602070113
It's a rat study which suggests that use of morphine may prolong chronic neuropathic pain (not new news) with the new finding of an association with a specific receptor protein which may lead to novel therapies.
I'd say we're looking at a decade before this line of research has any material effect on penthrox sales.
Morphine, page-5
Add MVP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.0¢ |
Change
-0.020(4.76%) |
Mkt cap ! $34.52M | |||
| Open | High | Low | Value | Volume |
| 41.5¢ | 42.5¢ | 40.0¢ | $19.58K | 48.35K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 17465 | 40.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 42.0¢ | 3592 | 4 |
View Market Depth
| Last trade - 13.37pm 31/07/2024 (20 minute delay) ? |
| MVP (ASX) Chart |